Revenue
0
2022 Q4 ·
Annual consolidated revenue for 2024: about USD 0, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2023, was about USD 0.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-19.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
0 USD
61741946 shares
79.22% · 27.3 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-25.1 million USD
2025-10-01 – 2026-09-30
-25.4 million USD
2025-10-01 – 2026-09-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-17.
Financial data available through: 2024-12-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 0
–
Current period
USD 0
–
0 − 0 = 0 USD
0 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source0 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 13.07 million
–
Current period
−USD 15.7 million
–
-15704461 − -13071016 = -2633445 USD
-13071016 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-15704461 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Net income, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | 0 | 7786627 Derived | -7786627 | Unavailable | Unavailable | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 0 | 16176201 Derived | -16176201 | Unavailable | Unavailable | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 0 | 20182381 Derived | -20182381 | Unavailable | Unavailable | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 0 | 16957210 Derived | -16957210 | 6297446 Derived | -23254656 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 0 |
|
| 2023 | Revenue | 0 |
|
| 2024 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | Not reported |
|
| 2023 | Operating margin | Not reported |
|
| 2024 | Operating margin | Not reported |
|
| 2021-12-31 | Net margin | Not reported |
|
| 2022-12-31 | Net margin | Not reported |
|
| 2023-12-31 | Net margin | Not reported |
|
| 2024 | Net margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -4122896 |
|
| 2022 | Operating cash flow | -12096104 |
|
| 2023 | Operating cash flow | -13071016 |
|
| 2024 | Operating cash flow | -15704461 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 18.9% |
|
| 2022 | Liabilities / assets | 29.2% |
|
| 2023 | Liabilities / assets | 93.7% |
|
| 2024 | Liabilities / assets | 64.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 4.97× |
|
| 2022 | Current assets / current liabilities | 3.61× |
|
| 2023 | Current assets / current liabilities | 1.53× |
|
| 2024 | Current assets / current liabilities | 2.65× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | Unavailable Not reported for this period. | −USD 1.84 million Exact valueExact value: -1844163 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | Unavailable Not reported for this period. | −USD 4.12 million Exact valueExact value: -4122896 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | Unavailable Not reported for this period. | −USD 12.1 million Exact valueExact value: -12096104 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | Unavailable Not reported for this period. | −USD 13.07 million Exact valueExact value: -13071016 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 23.25 million Exact valueExact value: -23254656 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.7 million Exact valueExact value: -15704461 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
33 filings · 1,085 latest values · 1,085 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001878313, 1878313, MAIA, edgar:1878313
Also known as MAIA BIOTECHNOLOGY, INC., MAIA Biotechnology, Inc.